US

Charlie Munger, the 99-year-old investor and vice chairman of Berkshire Hathaway, has expressed concerns over the US commercial property market. In an interview with the Financial Times, Munger stated that US banks are filled with “bad loans” that will become vulnerable as property prices fall and “bad times come”. Munger acknowledged that the current situation
Biogen CEO Christopher Viehbacher commented during the company’s first quarter earnings call that they are not worried about competing with Eli Lilly in the market for Alzheimer’s drugs. Both companies are working toward bringing their respective drugs to the market, with Biogen and Japanese drugmaker Eisai developing leqembi, and Eli Lilly developing donanemab and remternetug.